Boston Scientific Vercise Genus Bedienungsanleitung Seite 5

Introduction .................................................................................................................................................. 1
Description of the System ..................................................................................................................................2
Rechargeable IPG Battery Information ..............................................................................................................4
Non-Rechargeable IPG Battery Information ......................................................................................................6
Safety Information ....................................................................................................................................... 8
Indications for Use .............................................................................................................................................8
Patient Population ..............................................................................................................................................8
Intended Use ......................................................................................................................................................9
Clinical Benefit ...................................................................................................................................................9
Device Lifetime ...................................................................................................................................................9
Contraindications (When the Vercise Genus DBS System Should Not Be Used) ...........................................10
Warnings ..........................................................................................................................................................11
Precautions ......................................................................................................................................................18
Adverse Events ................................................................................................................................................27
Electromagnetic Compatibility ................................................................................................................. 32
EN 60601‑1‑2 Classification Information ..........................................................................................................32
Table of Contents
Information for Patients
92694767-14 v of vi